Investigation of two Wnt signalling pathway single nucleotide polymorphisms in a breast cancer-affected Australian population

Twin Research and Human Genetics

Volumn 14, Issue 6, 2011, Pages 562-567

  Gabrovska, Plamena N ^a   Smith, Robert A ^a   Haupt, Larisa M ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

association studies; breast cancer risk; Dye terminator DNA sequencing; genotyping; high resolution melt analysis; MARK4; PPP3CA; SNPs

Indexed keywords

CALCINEURIN 1; MICROTUBULE AFFINITY REGULATING KINASE 4; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CALCINEURIN; MARK4 PROTEIN, HUMAN; PPP3CA PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; AUSTRALIA; BREAST CANCER; CANCER RISK; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BREAST TUMOR; CASE CONTROL STUDY; DNA SEQUENCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR; TWINS; WNT SIGNALING PATHWAY;

AGED; AUSTRALIA; BREAST NEOPLASMS; CALCINEURIN; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; WNT SIGNALING PATHWAY;

EID: 84860792153     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.14.6.562     Document Type: Article

References (20)

1. Brennan, K. R., & Brown, A. M. (2004). Wnt proteins in mammary development and cancer. Journal of Mammary Gland Biology and Neoplasia, 9, 119-131. (Pubitemid 39177498)
2. Cadigan, K. M., & Nusse, R. (1997). Wnt signaling: A common theme in animal development. Genes and Development, 11, 3286-3305. (Pubitemid 28023954)
3. Chiocco, M. J., Zhu, X., Walther, D., Pletnikova, O., Troncoso, J. C., Uhl, G. R., & Liu, Q. R. (2010). Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease. Substance Use and Misuse, 45, 1809-1826.
4. Dash, R., Su, Z. Z., Lee, S. G., Azab, B., Boukerche, H., Sarkar, D., & Fisher, P. B. (2010). Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. Oncogene, 29, 4412-4423.
5. Ebneth, A., Drewes, G., Mandelkow, E. M., & Mandelkow, E. (1999). Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motility and the Cytoskeleton, 44, 209-224. (Pubitemid 29522234)
6. Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191.
7. Gabrovska, P. N., Smith, R. A., Tiang, T., Weinstein, S. R., Haupt, L. M. & Griffiths, L. R. (2011). Development of an eight gene expression profile implicating human breast tumours of all grade. Molecular Biology Reports.
8. Guerini, D., & Klee, C. B. (1989). Cloning of human calcineurin A: Evidence for two isozymes and identification of a polyproline structural domain. Proceedings of the National Academy of Sciences USA, 86, 9183-9187. (Pubitemid 20010389)
9. Howe, L. R., & Brown, A. M. (2004). Wnt signaling and breast cancer. Cancer Biology and Therapy, 3, 36-41.
10. Kato, T., Satoh, S., Okabe, H., Kitahara, O., Ono, K., Kihara, C., Tanaka, T., Tsunoda, T., Yamaoka, Y., Nakamura, Y., & Furukawa, Y. (2001). Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia, 3, 4-9. (Pubitemid 32201604)
11. Kinzler, K. W., & Vogelstein, B. (1996). Life (and death) in a malignant tumor. Nature, 379, 19-20.
12. Lea, R. A., Ovcaric, M., Sundholm, J., MacMillan, J., Griffiths, L. R. (2004). The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Medicine, 2, 3.
13. Lea, R. A., Selvey, S., Ashton, K. J., Curran, J. E., Gaffney, P. T., Green, A. C., & Griffiths, L. R. (1998). The null allele of GSTM1 does not affect susceptibility to solar keratoses in the Australian white population. Journal of the American Academy of Dermatology, 38, 631-633. (Pubitemid 28182939)
14. Sampath, D., Zhu, Y., Winneker, R. C., & Zhang, Z. (2001). Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism, 86, 1707-1715. (Pubitemid 32374927)
15. Sun, T. Q., Lu, B., Feng, J. J., Reinhard, C., Jan, Y. N., Fantl, W. J., & Williams, L. T. (2001). PAR-1 is a dishevelled-associated kinase and a positive regulator of Wnt signalling. Nature Cell Biology, 3, 628-636. (Pubitemid 32624418)
16. Trinczek, B., Brajenovic, M., Ebneth, A., & Drewes, G. (2004). MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. The Journal of Biological Chemistry, 279, 5915-5923. (Pubitemid 38220624)
17. Tsai, M. S., Bogart, D. F., Castaneda, J. M., Li, P., & Lupu, R. (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21, 8178-8185. (Pubitemid 35454421)
18. Vellon, L., Menendez, J. A., & Lupu, R. (2005). AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene, 24, 3759-3773. (Pubitemid 40826875)
19. Xie, D., Nakachi, K., Wang, H., Elashoff, R., & Koeffler, H. P. (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Research, 61, 8917-8923. (Pubitemid 34013909)
20. Zhang, Z., Hartmann, H., Do, V. M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., De Strooper, B., He, X., & Yankner, B. A. (1998). Destabilization of betacatenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature, 395, 698-702. (Pubitemid 28475966)